Zephyrus Biosciences

💰 Last funded 2014
Biotechnology Research🌐 zephyrusbio.com
Website LinkedIn
Zephyrus Biosciences provides research tools to enable protein analysis at the single cell level. Addressing the burgeoning single-cell analysis market, our first product enables western blotting on individual cells for the first time. Researchers will utilize Zephyrus’s products to gain new insights into the biology of cancer, stem cells, neurology, and human disease and development. Zephyrus spun out from Dr. Amy Herr’s laboratory at U.C. Berkeley in 2013 and is affiliated with QB3, BayBio, StartX Med, a Stanford-affiliated nonprofit technology accelerator, and Berkeley Skydeck, the premier accelerator at U.C. Berkeley.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Zephyrus Biosciences?
Zephyrus Biosciences has 1 investors on record on gritt.io.
When did Zephyrus Biosciences last raise funding?
The most recent investment in Zephyrus Biosciences recorded on gritt.io was in 2014.
What industry is Zephyrus Biosciences in?
Zephyrus Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.